Literature DB >> 28209420

[Importance of the emotional dimension when providing information to patients with obstructive sleep apnea syndrome].

J Bros1, C Poulet2, C Deschaux3, M Charavel2.   

Abstract

INTRODUCTION: To promote adaptation to treatment with continuous positive airway pressure, an information document was developed for people starting their treatment with continuous positive airway pressure.
METHODS: Seven patients with obstructive sleep apnea took part in a focus group. This allowed the identification both of useful information and the best way that this information could be presented.
RESULTS: The key specific information objectives and the best emotional register to use were as follows: (1) develop awareness about the physiological mechanisms and consequences that can occur from obstructive sleep apnea syndrome, using formulations arousing fear, (2) enable the recognition of the symptoms, risk factors and chronicity of this syndrome, (3) reassure and motivate the patient about treatment with continuous positive airway pressure.
CONCLUSIONS: To promote adaptation to positive airway pressure in early care, combining different emotional tones is preferable, mixing both fear and reassurance.
Copyright © 2017 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Emotion; Health education; Health information; Information en santé; Obstructive sleep apnea syndrome; Syndrome d’apnées obstructives du sommeil; Éducation pour la santé; Émotion

Mesh:

Year:  2017        PMID: 28209420     DOI: 10.1016/j.rmr.2016.10.876

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  1 in total

1.  "It is what I tell her that she will do": a mixed methods study of married men's knowledge and attitude towards supporting their wives' cervical cancer screening in rural South-East Nigeria.

Authors:  Ijeoma Nkem Okedo-Alex; Chigozie Jesse Uneke; Henry Chukwuemeka Uro-Chukwu; Ifeyinwa Chizoba Akamike; Onyedikachi Echefu Chukwu
Journal:  Pan Afr Med J       Date:  2020-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.